BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20813000)

  • 21. [Association of XRCC1 genetic polymorphism with susceptibility to non-Hodgkin's lymphoma].
    Li SX; Zhu HL; Guo B; Yang Y; Wang HY; Sun JF; Cao YB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):982-7. PubMed ID: 25130814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia.
    Lee KM; Lan Q; Kricker A; Purdue MP; Grulich AE; Vajdic CM; Turner J; Whitby D; Kang D; Chanock S; Rothman N; Armstrong BK
    Hum Genet; 2007 Dec; 122(5):525-33. PubMed ID: 17891500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occupational solvent exposure, genetic variation of DNA repair genes, and the risk of non-Hodgkin's lymphoma.
    Jiao J; Zheng T; Lan Q; Chen Y; Deng Q; Bi X; Kim C; Holford T; Leaderer B; Boyle P; Ba Y; Xia Z; Chanock SJ; Rothman N; Zhang Y
    Eur J Cancer Prev; 2012 Nov; 21(6):580-4. PubMed ID: 22430443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms in methylenetetrahydrofolate reductase gene and risk of non-Hodgkin lymphoma in a multi-ethnic population.
    Suthandiram S; Gan GG; Zain SM; Haerian BS; Bee PC; Lian LH; Chang KM; Ong TC; Mohamed Z
    J Hum Genet; 2014 May; 59(5):280-7. PubMed ID: 24646728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-nucleotide polymorphisms in genes encoding for CC chemokines were not associated with the risk of non-Hodgkin lymphoma.
    Chen Q; Zheng T; Lan Q; Lerro C; Zhao N; Qin Q; Hu X; Huang H; Liang J; Holford T; Leaderer B; Boyle P; Chanock SJ; Rothman N; Zhang Y
    Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1332-5. PubMed ID: 23640258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma.
    Gathany AH; Hartge P; Davis S; Cerhan JR; Severson RK; Cozen W; Rothman N; Chanock SJ; Wang SS
    Cancer Causes Control; 2009 Oct; 20(8):1291-302. PubMed ID: 19396635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms in the nucleotide excision repair gene ERCC2/XPD and risk of non-Hodgkin lymphoma.
    Worrillow L; Roman E; Adamson PJ; Kane E; Allan JM; Lightfoot TJ
    Cancer Epidemiol; 2009 Oct; 33(3-4):257-60. PubMed ID: 19736055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies.
    Lan Q; Morton LM; Armstrong B; Hartge P; Menashe I; Zheng T; Purdue MP; Cerhan JR; Zhang Y; Grulich A; Cozen W; Yeager M; Holford TR; Vajdic CM; Davis S; Leaderer B; Kricker A; Schenk M; Zahm SH; Chatterjee N; Chanock SJ; Rothman N; Wang SS
    Blood; 2009 Jul; 114(2):264-7. PubMed ID: 19414860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma.
    Novik KL; Spinelli JJ; Macarthur AC; Shumansky K; Sipahimalani P; Leach S; Lai A; Connors JM; Gascoyne RD; Gallagher RP; Brooks-Wilson AR
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1098-106. PubMed ID: 17548670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma.
    Song H; Tong D; Cha Z; Bai J
    Mol Biol Rep; 2012 Sep; 39(9):8629-35. PubMed ID: 22707196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphisms in nitric oxide synthase genes modify the relationship between vegetable and fruit intake and risk of non-Hodgkin lymphoma.
    Han X; Zheng T; Lan Q; Zhang Y; Kilfoy BA; Qin Q; Rothman N; Zahm SH; Holford TR; Leaderer B; Zhang Y
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1429-38. PubMed ID: 19423521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma.
    Purdue MP; Lan Q; Wang SS; Kricker A; Menashe I; Zheng TZ; Hartge P; Grulich AE; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Leaderer BP; Cerhan JR; Yeager M; Cozen W; Jacobs K; Davis S; Rothman N; Chanock SJ; Chatterjee N; Armstrong BK
    Carcinogenesis; 2009 Feb; 30(2):275-81. PubMed ID: 19029192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.
    Cerhan JR; Fredericksen ZS; Novak AJ; Ansell SM; Kay NE; Liebow M; Dogan A; Cunningham JM; Wang AH; Witzig TE; Habermann TM; Asmann YW; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1799-806. PubMed ID: 22911334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma.
    Skibola DR; Smith MT; Bracci PM; Hubbard AE; Agana L; Chi S; Holly EA
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1251-6. PubMed ID: 15894681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between organochlorines and the AHR gene, and risk of non-Hodgkin lymphoma.
    Ng CH; Janoo-Gilani R; Sipahimalani P; Gallagher RP; Gascoyne RD; Connors JM; Weber JP; Lai AS; Leach S; Le ND; Brooks-Wilson AR; Spinelli JJ
    Cancer Causes Control; 2010 Jan; 21(1):11-22. PubMed ID: 19821039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C677T and A1298C polymorphisms of methylene tetrahydrofolate reductase in non-Hodgkin lymphoma: southeast Iran.
    Mashhadi MA; Miri-Moghaddam E; Arbabi N; Bazi A; Heidari Z; Sepehri Z; Karimkoshte A; Rezvan A; Hashemi SM
    Tumori; 2018 Aug; 104(4):280-284. PubMed ID: 28430351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes.
    Hill DA; Wang SS; Cerhan JR; Davis S; Cozen W; Severson RK; Hartge P; Wacholder S; Yeager M; Chanock SJ; Rothman N
    Blood; 2006 Nov; 108(9):3161-7. PubMed ID: 16857995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes.
    Slager SL; Camp NJ; Conde L; Shanafelt TD; Achenbach SJ; Rabe KG; Kay NE; Novak AJ; Call TG; Bracci PM; Sille FM; Sanchez S; Akers NK; Cunningham JM; Serie DJ; McDonnell SK; Leis JF; Wang AH; Weinberg JB; Glenn M; Link B; Vachon CM; Lanasa MC; Skibola CF; Cerhan JR
    Br J Haematol; 2012 Dec; 159(5):572-6. PubMed ID: 23025533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA repair gene polymorphisms in B cell non-Hodgkin's lymphoma.
    Bahceci A; Paydas S; Tanriverdi K; Ergin M; Seydaoglu G; Ucar G
    Tumour Biol; 2015 Mar; 36(3):2155-61. PubMed ID: 25400036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Caspase 8, 9 Gene Polymorphisms on Non-Hodgkin Lymphoma Susceptibility and Clinical/Pathological Features.
    Barati F; Bahari G; Asadi A; Nakhaee A; Hashemi SM; Taheri M; Hashemi M
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4339-4346. PubMed ID: 36580018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.